Wealth in Singapore: Sizing the Market Opportunity
SummarySingapore is one of the world’s pre-eminent offshore investment centers, with 81% of the wealth invested in funds sourced from non-residents. However, the onshore market is a major source of assets under management (AUM) in its own right, with 1.0 million affluent individuals despite the city state’s small population. As a regional trading hub Singapore’s growth rates are closely tied to the health of regional powerhouses such as China, India, and Indonesia; however, even with growth slowing in some of these economies, Singapore’s wealth market will continue to post rates that are the envy of the developed world.
Key Findings
- Â HNW individuals totaled 29,600 in 2015, a tiny proportion of the overall population and well below the levels seen in the US or Switzerland.
- Â HNW liquid assets are expected to grow by roughly 7.5% a year between 2015 and 2019.
- Â Bonds will be the fastest-growing asset class, but more due to greater availability than client demand.
-  While Singapore attracts significant offshore investment, residents are also keen to invest abroad – 34% of AUM is invested offshore
Synopsis
Verdict Financial’s “Wealth in Singapore: Sizing the Market Opportunity†analyzes the Singaporean wealth and retail savings and investments markets, with a focus on the HNW segment. The report is based on our proprietary datasets.
Specifically the report:
- Â Sizes the affluent market (both by the number of individuals and the value of their liquid assets) using our proprietary datasets.
- Â Analyzes which asset classes are favored by Singaporean retail investors and how their preferences impact the growth of the total savings and investments market.
-  Examines HNW clients’ attitudes towards non-liquid investments, such as hedge funds, property and commodities.
- Â Identifies key drivers and booking centers for offshore investments by Singaporean HNW clients.
Reasons To Buy
- Â Benchmark your share of the Singaporean wealth market against the current market size.
- Â Forecast your future growth prospects using our projections for the market to 2019.
- Â Identify your most promising client segment by analyzing penetration of affluent individuals in Singapore.
- Â Evaluate your HNW proposition by understanding the investment mix of the local onshore investment market.
- Â Review your offshore strategy by learning HNW motivations for offshore investments and their preferred booking centers.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.